Big Move For TNF Pharmaceuticals, Inc.
Wed, Oct 08, 2025 at 07:54 PM
TNF Pharmaceuticals, Inc. (TNFA:NASDAQ) soared at $5.2, representing a gain of 48.1%. The stock got featured on our News Catalysts scanner on Wed, Sep 24, 2025 at 10:49 AM in the 'MISCELLANEOUS' category. From Wed, Sep 24, 2025, the stock recorded 40.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Oct 03, 2025 at $8.9 with a volume of 60M+.
About TNF Pharmaceuticals, Inc. (TNFA:NASDAQ)
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms.
Top 10 Gainers:
- Xenetic Biosciences, Inc. (XBIO:NASDAQ), 141.49%
- Nexalin Technology, Inc. (NXL:NASDAQ), 98.25%
- AlphaTON Capital Corp Shs (New) (ATON:NASDAQ), 95.52%
- Acurx Pharmaceuticals, Inc. (ACXP:NASDAQ), 89.25%
- Universe Pharmaceuticals INC (UPC:NASDAQ), 82.98%
- Adaptimmune Therapeutics plc (ADAP:NASDAQ), 51.88%
- TNF Pharmaceuticals, Inc. (TNFA:NASDAQ), 48.15%
- XTL Biopharmaceuticals Ltd. (XTLB:NASDAQ), 46.43%
- TNL Mediagene (TNMG:NASDAQ), 45.5%
- Soluna Holdings, Inc. (SLNH:NASDAQ), 39.41%